JCHAIN
gene geneOn this page
Also known as IGCJJCH
Summary
JCHAIN (joining chain of multimeric IgA and IgM, HGNC:5713) is a protein-coding gene on chromosome 4q13.3, encoding Immunoglobulin J chain (P01591). Serves to link two monomer units of either IgM or IgA.
Enables IgA binding activity and protein homodimerization activity. Contributes to several functions, including immunoglobulin receptor binding activity; peptidoglycan binding activity; and phosphatidylcholine binding activity. Involved in several processes, including glomerular filtration; innate immune response; and positive regulation of respiratory burst. Located in extracellular space. Part of monomeric IgA immunoglobulin complex; pentameric IgM immunoglobulin complex; and secretory dimeric IgA immunoglobulin complex.
Source: NCBI Gene 3512 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 19 total
- MANE Select transcript:
NM_144646
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:5713 |
| Approved symbol | JCHAIN |
| Name | joining chain of multimeric IgA and IgM |
| Location | 4q13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | IGCJ, JCH |
| Ensembl gene | ENSG00000132465 |
| Ensembl biotype | protein_coding |
| OMIM | 147790 |
| Entrez | 3512 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 protein_coding
ENST00000254801, ENST00000391614, ENST00000470866, ENST00000510437, ENST00000510614, ENST00000856250, ENST00000944536
RefSeq mRNA: 1 — MANE Select: NM_144646
NM_144646
CCDS: CCDS3545
Canonical transcript exons
ENST00000254801 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000720299 | 70657211 | 70657291 |
| ENSE00001138846 | 70662092 | 70662215 |
| ENSE00001170989 | 70666427 | 70666508 |
| ENSE00001296649 | 70655541 | 70656539 |
Expression profiles
Bgee: expression breadth ubiquitous, 234 present calls, max score 99.96.
FANTOM5 (CAGE): breadth broad, TPM avg 42.9391 / max 4245.1626, expressed in 381 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 52430 | 31.7334 | 204 |
| 52431 | 7.7551 | 179 |
| 52432 | 2.4983 | 229 |
| 203210 | 0.4426 | 80 |
| 52433 | 0.2678 | 50 |
| 52434 | 0.2420 | 50 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| rectum | UBERON:0001052 | 99.96 | gold quality |
| jejunal mucosa | UBERON:0000399 | 99.92 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 99.89 | gold quality |
| pylorus | UBERON:0001166 | 99.83 | gold quality |
| caecum | UBERON:0001153 | 99.77 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 99.75 | gold quality |
| vermiform appendix | UBERON:0001154 | 99.73 | gold quality |
| colonic mucosa | UBERON:0000317 | 99.63 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 99.62 | gold quality |
| nasopharynx | UBERON:0001728 | 99.61 | gold quality |
| duodenum | UBERON:0002114 | 99.58 | gold quality |
| trachea | UBERON:0003126 | 99.34 | gold quality |
| tonsil | UBERON:0002372 | 99.28 | gold quality |
| cardia of stomach | UBERON:0001162 | 99.27 | gold quality |
| parotid gland | UBERON:0001831 | 99.19 | gold quality |
| spleen | UBERON:0002106 | 99.07 | gold quality |
| colonic epithelium | UBERON:0000397 | 99.02 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 98.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.88 | gold quality |
| mammary duct | UBERON:0001765 | 98.81 | gold quality |
| gall bladder | UBERON:0002110 | 98.78 | gold quality |
| bone marrow cell | CL:0002092 | 98.60 | gold quality |
| lower lobe of lung | UBERON:0008949 | 98.18 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 98.16 | gold quality |
| ileal mucosa | UBERON:0000331 | 98.08 | gold quality |
| lymph node | UBERON:0000029 | 97.76 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 97.59 | gold quality |
| monocyte | CL:0000576 | 97.33 | gold quality |
| mononuclear cell | CL:0000842 | 97.28 | gold quality |
| adult organism | UBERON:0007023 | 97.04 | gold quality |
Single-cell (SCXA)
Detected in 54 experiment(s), a significant marker in 53.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-46 | yes | 109570.68 |
| E-CURD-89 | yes | 97280.35 |
| E-CURD-88 | yes | 94401.51 |
| E-MTAB-8410 | yes | 87773.90 |
| E-HCAD-11 | yes | 77311.24 |
| E-GEOD-125970 | yes | 51047.45 |
| E-CURD-122 | yes | 40971.21 |
| E-MTAB-8322 | yes | 31973.86 |
| E-MTAB-9543 | yes | 30078.96 |
| E-MTAB-6386 | yes | 29479.17 |
| E-MTAB-6653 | yes | 29176.77 |
| E-HCAD-1 | yes | 26948.02 |
| E-MTAB-8142 | yes | 26221.73 |
| E-HCAD-15 | yes | 20767.53 |
| E-MTAB-8207 | yes | 19534.51 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MEF2A, MEF2C, PAX5, SPI1, TCF3, USF1
miRNA regulators (miRDB)
54 targeting JCHAIN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-5197-5P | 99.64 | 69.08 | 1494 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-4273 | 99.45 | 67.93 | 1206 |
| HSA-MIR-1276 | 99.36 | 68.18 | 1642 |
| HSA-MIR-155-5P | 99.35 | 70.16 | 1509 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-499A-3P | 99.18 | 69.20 | 1392 |
| HSA-MIR-499B-3P | 99.18 | 69.27 | 1391 |
| HSA-MIR-4763-3P | 99.10 | 67.83 | 2649 |
| HSA-MIR-3168 | 99.08 | 67.75 | 1384 |
| HSA-MIR-6737-3P | 98.95 | 68.56 | 1577 |
Literature-anchored findings (GeneRIF, showing 3)
- TLR2 ligands induce CCR9 and CCR10 expression by circulating B-cells and increase their chemotaxis. TLR2 stimulation also induced J chain and IgA production demonstrating the induction of mucosal-like antibody secreting cells. (PMID:20947433)
- Results show that ID1, ID3 and IGJ genes are highly expressed in adult B-ALL and correlate with poor prognosis in Hispanic patients. (PMID:27044543)
- IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF-kappaB signaling pathway. (PMID:37539706)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Jchain | ENSMUSG00000067149 |
| rattus_norvegicus | Jchain | ENSRNOG00000003666 |
Protein
Protein identifiers
Immunoglobulin J chain — P01591 (reviewed: P01591)
Alternative names: Joining chain of multimeric IgA and IgM
All UniProt accessions (4): P01591, C9JA05, D6RD17, D6RHJ6
UniProt curated annotations — full annotation on UniProt →
Function. Serves to link two monomer units of either IgM or IgA. In the case of IgM, the J chain-joined dimer is a nucleating unit for the IgM pentamer, and in the case of IgA it induces dimers and/or larger polymers. It also helps to bind these immunoglobulins to secretory component.
Subunit / interactions. Part of the secretory IgA (sIgA) complex that consists of two, four or five IgA monomers, and two additional non-Ig polypeptides, namely the JCHAIN and the secretory component (the proteolytic product of PIGR). Part of the secretory IgM (sIgM) complex that consists of five IgM monomers, and two additional non-Ig polypeptides, namely the JCHAIN and the secretory component (the proteolytic product of PIGR). JCHAIN-containing IgM interacts (via CH4 domain) with FCRM (via Ig-like domain).
Subcellular location. Secreted.
RefSeq proteins (1): NP_653247* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024110 | Ig_J | Family |
Pfam: PF15097
UniProt features (25 total): strand 13, disulfide bond 5, turn 2, signal peptide 1, chain 1, helix 1, modified residue 1, glycosylation site 1
Structure
Experimental structures (PDB)
30 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6UE7 | ELECTRON MICROSCOPY | 2.9 |
| 6UE9 | ELECTRON MICROSCOPY | 2.9 |
| 6UE8 | ELECTRON MICROSCOPY | 3 |
| 6UEA | ELECTRON MICROSCOPY | 3 |
| 8SKV | ELECTRON MICROSCOPY | 3.1 |
| 6LX3 | ELECTRON MICROSCOPY | 3.15 |
| 7YSG | ELECTRON MICROSCOPY | 3.18 |
| 8SKU | ELECTRON MICROSCOPY | 3.2 |
| 6LXW | ELECTRON MICROSCOPY | 3.27 |
| 7K0C | ELECTRON MICROSCOPY | 3.3 |
| 7YG2 | ELECTRON MICROSCOPY | 3.32 |
| 7YTC | ELECTRON MICROSCOPY | 3.39 |
| 8WYR | ELECTRON MICROSCOPY | 3.39 |
| 6KXS | ELECTRON MICROSCOPY | 3.4 |
| 8WYS | ELECTRON MICROSCOPY | 3.41 |
| 8BPF | ELECTRON MICROSCOPY | 3.5 |
| 7Y0H | ELECTRON MICROSCOPY | 3.56 |
| 8R83 | ELECTRON MICROSCOPY | 3.57 |
| 8GZN | ELECTRON MICROSCOPY | 3.6 |
| 8R84 | ELECTRON MICROSCOPY | 3.6 |
| 9ARV | ELECTRON MICROSCOPY | 3.6 |
| 7Y0J | ELECTRON MICROSCOPY | 3.62 |
| 8BPE | ELECTRON MICROSCOPY | 3.63 |
| 7Y09 | ELECTRON MICROSCOPY | 3.71 |
| 7YTD | ELECTRON MICROSCOPY | 3.71 |
| 8ADY | ELECTRON MICROSCOPY | 5.2 |
| 8ADZ | ELECTRON MICROSCOPY | 6.7 |
| 8AE3 | ELECTRON MICROSCOPY | 6.8 |
| 8AE0 | ELECTRON MICROSCOPY | 7.1 |
| 8AE2 | ELECTRON MICROSCOPY | 8.5 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P01591-F1 | 87.13 | 0.60 |
Antibody-complex structures (SAbDab): 5 — 8ADY, 8ADZ, 8AE0, 8AE2, 8AE3
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 23
Disulfide bonds (5): 35–123, 37, 91, 94–114, 131–156
Glycosylation sites (1): 71
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-202733 | Cell surface interactions at the vascular wall |
| R-HSA-2168880 | Scavenging of heme from plasma |
MSigDB gene sets: 269 (showing top):
GOBP_REGULATION_OF_RESPIRATORY_BURST, WALLACE_PROSTATE_CANCER_RACE_UP, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, MCLACHLAN_DENTAL_CARIES_UP, MODULE_45, MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN, CROONQUIST_NRAS_SIGNALING_UP, MEF2_02, GOLDRATH_ANTIGEN_RESPONSE, chr4q13, HAHTOLA_MYCOSIS_FUNGOIDES_DN, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
GO Biological Process (8): adaptive immune response (GO:0002250), glomerular filtration (GO:0003094), immune response (GO:0006955), humoral immune response (GO:0006959), antibacterial humoral response (GO:0019731), innate immune response (GO:0045087), positive regulation of respiratory burst (GO:0060267), protein-containing complex assembly (GO:0065003)
GO Molecular Function (8): antigen binding (GO:0003823), IgA binding (GO:0019862), protein-macromolecule adaptor activity (GO:0030674), immunoglobulin receptor binding (GO:0034987), protein homodimerization activity (GO:0042803), single-stranded DNA binding (GO:0003697), phosphatidylcholine binding (GO:0031210), peptidoglycan binding (GO:0042834)
GO Cellular Component (9): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), extracellular exosome (GO:0070062), monomeric IgA immunoglobulin complex (GO:0071748), dimeric IgA immunoglobulin complex (GO:0071750), secretory IgA immunoglobulin complex (GO:0071751), secretory dimeric IgA immunoglobulin complex (GO:0071752), pentameric IgM immunoglobulin complex (GO:0071756), blood microparticle (GO:0072562)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Hemostasis | 1 |
| Binding and Uptake of Ligands by Scavenger Receptors | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| immune response | 3 |
| cellular anatomical structure | 2 |
| polymeric IgA immunoglobulin complex | 2 |
| renal filtration | 1 |
| immune system process | 1 |
| response to stimulus | 1 |
| antimicrobial humoral response | 1 |
| defense response to bacterium | 1 |
| defense response to symbiont | 1 |
| positive regulation of metabolic process | 1 |
| respiratory burst | 1 |
| regulation of respiratory burst | 1 |
| cellular component assembly | 1 |
| protein-containing complex organization | 1 |
| binding | 1 |
| immunoglobulin binding | 1 |
| protein binding | 1 |
| molecular adaptor activity | 1 |
| signaling receptor binding | 1 |
| identical protein binding | 1 |
| protein dimerization activity | 1 |
| DNA binding | 1 |
| phospholipid binding | 1 |
| cation binding | 1 |
| quaternary ammonium group binding | 1 |
| glycosaminoglycan binding | 1 |
| extracellular vesicle | 1 |
| IgA immunoglobulin complex, circulating | 1 |
| dimeric IgA immunoglobulin complex | 1 |
| secretory IgA immunoglobulin complex | 1 |
| IgM immunoglobulin complex, circulating | 1 |
| extracellular region | 1 |
Protein interactions and networks
STRING
1822 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| JCHAIN | PIGR | P01833 | 999 |
| JCHAIN | UTP3 | Q9NQZ2 | 923 |
| JCHAIN | ERP44 | Q9BS26 | 870 |
| JCHAIN | ERO1B | Q86YB8 | 833 |
| JCHAIN | LAP3 | P28838 | 766 |
| JCHAIN | PIGA | P37287 | 760 |
| JCHAIN | FCAR | P24071 | 715 |
| JCHAIN | IGLL5 | B9A064 | 699 |
| JCHAIN | ERO1A | Q96HE7 | 661 |
| JCHAIN | IGLL1 | P15814 | 647 |
| JCHAIN | PGM2 | Q96G03 | 647 |
| JCHAIN | MZB1 | Q8WU39 | 643 |
| JCHAIN | IGHV4-38-2 | P0DP08 | 588 |
| JCHAIN | CD79A | P11912 | 575 |
| JCHAIN | CBFB | Q13951 | 549 |
IntAct
96 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SMARCE1 | ARID1A | psi-mi:“MI:0914”(association) | 0.840 |
| ARMCX3 | RANBP6 | psi-mi:“MI:0914”(association) | 0.730 |
| SNW1 | AQR | psi-mi:“MI:0914”(association) | 0.650 |
| RPL10A | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| FRMD1 | A2ML1 | psi-mi:“MI:0914”(association) | 0.530 |
| DDX31 | IGLL5 | psi-mi:“MI:0914”(association) | 0.530 |
| HBM | SCGB2A1 | psi-mi:“MI:0914”(association) | 0.530 |
| ICE2 | HP | psi-mi:“MI:0914”(association) | 0.530 |
| RHOBTB1 | CST4 | psi-mi:“MI:0914”(association) | 0.530 |
| GTF2B | CST4 | psi-mi:“MI:0914”(association) | 0.530 |
| PLEKHG6 | CST4 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF491 | CST4 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIAP1 | JCHAIN | psi-mi:“MI:0914”(association) | 0.530 |
| APCDD1 | JCHAIN | psi-mi:“MI:0914”(association) | 0.530 |
| SLC25A15 | JCHAIN | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM237 | CLGN | psi-mi:“MI:0914”(association) | 0.530 |
| KIR2DS2 | RHOBTB3 | psi-mi:“MI:0914”(association) | 0.530 |
| NPB | CST4 | psi-mi:“MI:0914”(association) | 0.530 |
| RIBC1 | CNOT1 | psi-mi:“MI:0914”(association) | 0.530 |
| LECT2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (87): IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGJ (Affinity Capture-MS)
ESM2 similar proteins: A0A385DTH1, A0A7H0DN76, A4ZUA0, A6LT23, C3KVX7, C4LBG4, D4H539, J7T0S1, O10620, O34838, P01591, P07970, P07971, P0C6F5, P0C6F8, P0C6T4, P0C6T7, P0C6V9, P0C6W2, P0C6W3, P0C6W6, P0CA95, P0CAB9, P0DTC1, P0DTD1, P0DUB2, P17003, P17004, P17005, P23108, P29815, P52471, P87691, Q04916, Q45UF8, Q5UNX6, Q5UPF9, Q5UPS4, Q5UQG1, Q5UQT5
Diamond homologs: P01591, P01592, P0DUB2, P23108
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
545 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:70656535:TACAG:T | acceptor_gain | 1.0000 |
| 4:70656536:ACAG:A | acceptor_gain | 1.0000 |
| 4:70656537:CAG:C | acceptor_gain | 1.0000 |
| 4:70656537:CAGC:C | acceptor_gain | 1.0000 |
| 4:70656538:AG:A | acceptor_gain | 1.0000 |
| 4:70656538:AGC:A | acceptor_loss | 1.0000 |
| 4:70656539:GCT:G | acceptor_loss | 1.0000 |
| 4:70656540:C:CC | acceptor_gain | 1.0000 |
| 4:70657209:A:AC | donor_gain | 1.0000 |
| 4:70657210:C:CC | donor_gain | 1.0000 |
| 4:70657210:CAGGT:C | donor_gain | 1.0000 |
| 4:70657234:T:C | donor_gain | 1.0000 |
| 4:70657287:GAACA:G | acceptor_gain | 1.0000 |
| 4:70657289:ACA:A | acceptor_gain | 1.0000 |
| 4:70657289:ACAC:A | acceptor_loss | 1.0000 |
| 4:70657290:CA:C | acceptor_gain | 1.0000 |
| 4:70657290:CAC:C | acceptor_gain | 1.0000 |
| 4:70657290:CACTA:C | acceptor_loss | 1.0000 |
| 4:70657291:AC:A | acceptor_loss | 1.0000 |
| 4:70657292:C:CA | acceptor_loss | 1.0000 |
| 4:70657292:C:CC | acceptor_gain | 1.0000 |
| 4:70657293:T:C | acceptor_loss | 1.0000 |
| 4:70662088:ATAC:A | donor_loss | 1.0000 |
| 4:70662089:TA:T | donor_loss | 1.0000 |
| 4:70662090:A:AC | donor_gain | 1.0000 |
| 4:70662090:A:AG | donor_loss | 1.0000 |
| 4:70662091:C:CC | donor_gain | 1.0000 |
| 4:70662091:CAT:C | donor_gain | 1.0000 |
| 4:70662091:CATA:C | donor_gain | 1.0000 |
| 4:70662091:CATAA:C | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000552678 (4:70660106 C>G), RS1000618997 (4:70664161 A>C,G,T), RS1000694371 (4:70664006 A>C,G), RS1000882902 (4:70664792 T>C), RS1001092244 (4:70659298 C>A), RS1001283766 (4:70667238 A>G), RS1001461295 (4:70659604 G>A,C), RS1001563774 (4:70660435 C>T), RS1001722862 (4:70661102 A>G), RS1001961911 (4:70655568 A>G), RS1002057035 (4:70660176 A>G), RS1002279351 (4:70659224 T>A), RS1002417138 (4:70664390 G>A), RS1002689937 (4:70665414 C>A,T), RS1002721432 (4:70663612 G>A)
Disease associations
OMIM: gene MIM:147790 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | affects binding, decreases expression, increases expression | 3 |
| Zinc | affects binding, increases expression | 2 |
| propionaldehyde | increases methylation | 1 |
| nonanal | increases methylation | 1 |
| n-hexanal | increases methylation | 1 |
| arsenite | decreases methylation | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | increases methylation | 1 |
| tetrathiomolybdate | increases expression | 1 |
| caprylic aldehyde | increases methylation | 1 |
| hydroquinone | decreases expression | 1 |
| pentanal | increases methylation | 1 |
| heptanal | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| incobotulinumtoxinA | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Cadmium | affects binding | 1 |
| Demecolcine | decreases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydroxychloroquine | affects cotreatment, decreases expression | 1 |
| Lead | affects binding | 1 |
| Methotrexate | affects cotreatment, decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Pesticides | increases expression | 1 |
| Sulfasalazine | affects cotreatment, decreases expression | 1 |
| Dronabinol | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.